Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors Journal Article


Authors: Chmielecki, J.; Crago, A. M.; Rosenberg, M.; O'Connor, R.; Walker, S. R.; Ambrogio, L.; Auclair, D.; McKenna, A.; Heinrich, M. C.; Frank, D. A.; Meyerson, M.
Article Title: Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors
Abstract: Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs. © 2013 Nature America, Inc. All rights reserved.
Keywords: unclassified drug; reverse transcription polymerase chain reaction; gene locus; transcription factor; tumor recurrence; fibroma; dna sequence; repressor protein; soft tissue tumor; dna transcription; exome; stat6 protein; transcription factor nab2
Journal Title: Nature Genetics
Volume: 45
Issue: 2
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2013-02-01
Start Page: 131
End Page: 132
Language: English
DOI: 10.1038/ng.2522
PROVIDER: scopus
PUBMED: 23313954
PMCID: PMC3984043
DOI/URL:
Notes: --- - "Export Date: 1 March 2013" - "CODEN: NGENE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Aimee Marie Crago
    106 Crago